Jefferies Financial Group Boosts LifeStance Health Group (NASDAQ:LFST) Price Target to $9.00

LifeStance Health Group (NASDAQ:LFST – Free Report) had its price target upped by Jefferies Financial Group from $8.00 to $9.00 in a research report released on Wednesday morning, Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. Several other research firms have also recently commented on LFST. Barclays boosted their price […]

Related Keywords

Kevin Michael Mullins ,Lifestance Health Group ,Securities Exchange Commission ,Proshare Advisors ,News Ratings For Lifestance Health Group Daily ,Jefferies Financial Group ,Jpmorgan Chase Co ,Analyst Recommendations For Lifestance Health Group ,Lifestance Health Group Company Profile ,Barclays ,Metlife Investment Management ,Lifestance Health Group Inc ,Goldman Sachs Group ,Lifestance Health Group Price Performance ,York Mellon Corp ,Free Report ,Financial Group ,Exchange Commission ,Share Advisors ,New York Mellon Corp ,Life Investment Management ,Rhumbline Advisers ,Get Free Report ,Stance Health Group ,Lifestance Health Group Daily ,